SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-24-000152
Filing Date
2024-08-20
Accepted
2024-08-20 16:20:43
Documents
15
Period of Report
2024-08-20
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20240820.htm   iXBRL 8-K 29764
2 EX-99.1 pressrelease_08202024.htm EX-99.1 11012
6 image.jpg GRAPHIC 7489
  Complete submission text file 0001367644-24-000152.txt   181108

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20240820.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20240820_lab.xml EX-101.LAB 22804
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20240820_pre.xml EX-101.PRE 13102
17 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20240820_htm.xml XML 2819
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 241225415
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)